Frontiers | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update | Oncology
The Epstein–Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of individuals worldwide and has been linked to several malignancies including PTLDs, which are one of the most common malignancies following transplantation. Among all the EBV genes, most of the recent investigations focused on studying the LMP-1 oncogene because of its high degree of polymorphism and association with tumorigenic activity. There are two main EBV genotypes, Type 1 and 2, distinguished by the differences in the EBNA-2 gene. Further sub genotyping can be characterized by analyzing the LMP-1 gene variation. The virus primarily transmits through oral secretions and persists as a latent infection in human B-cells. However, it can be transmitted through organ transplantations and blood transfusions. In addition, symptoms of EBV infection are not distinguishable from other viral infections, and therefore, it remains questionable whether there is a need to screen for EBV prior to blood transfusion. Although the process of leukoreduction decreases the viral copies present in the leukocytes, it does not eliminate the risk of EBV transmission through blood products. Here, we provide a review of the EBV epidemiology and the genetic variability of the oncogene LMP-1. Then, we underscore the findings of recent EBV seroprevalence and viremia studies among blood donors as a highly prevalent transfusion t...
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,G as k,J as F,B as L,C as P,X as U,D as j,E as q,F as z,H as $,I as V,L as H,M as W,N as G,O as K,P as Z,Q as Y,R as J,T as X,U as Q,V as AA,W as eA,Y as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA}fr
saved by
related reading
- Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Updatefrontiersin.org
- Clinical manifestations and treatment of Epstein-Barr virus infectionuptodate.com
- Frontiers | The Role of NK Cells and Innate Lymphoid Cells in Brain Cancerfrontiersin.org
- HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection - PMCncbi.nlm.nih.gov
- Frontiers | Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective studyfrontiersin.org
- Frontiers | Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Diseasefrontiersin.org
- Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org
- HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
- Frontiers | Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Groupfrontiersin.org
- HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
- Frontiers | On the Cost of Knowledge: Evaluating the Boycott against Elsevierfrontiersin.org
- Frontiers | Organic Molecules in Interstellar Space: Latest Advancesfrontiersin.org